Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

TBXU vs. CURE: which is better?

Bottom line

TBXU vs CURE: the short answer

TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF) and CURE (Direxion Daily Healthcare Bull 3X ETF) are quite different portfolios: only about 39% of their top holdings (by weight) are shared.

But CURE is far broader, holding 67 positions to 10 for TBXU, so beyond the top names it adds exposure TBXU doesn't have.

CURE is cheaper at 0.94% vs 0.98% — a difference of $4.00 a year per $10,000 invested.

Updated Nov 19, 2026

TBXU vs CURE side by side

TBXUCURE
TypeETFETF
Fund familyDirexionDirexion
CategoryLeveraged & InverseLeveraged & Inverse
Expense ratio0.98%0.94%
Annual cost per $10k$98$94
10-yr cost on $10k (prospectus)$5,645$1,155
Max front loadNoneNone
12b-1 fee0%0%
1-yr return—+22.9%
5-yr return (annualized)—+8.6%
10-yr return (annualized)—+13.6%
Best quarter—+46.9%
Worst quarter—−45.8%
Net assets (fund)$2.6M$171.7M
Number of holdings1067
Portfolio turnover69%1%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

8 of TBXU's top 10 holdings also appear in CURE's top 25.

Shared top holdings
HoldingTBXUCURE
Goldman Financial29.36%7.51%
Dreyfus21.64%18.79%
Amgen Inc7.95%2.38%
Vertex Pharmaceuticals Inc7.84%1.39%
Gilead Sciences Inc7.58%1.85%
Goldman Sachs Liq Es Fd A6.23%8.19%
N/a2.83%1.12%
N/a0.62%1.12%

Source: SEC Form N-PORT

TBXU top 10

  1. Goldman Financial — 29.36%
  2. Dreyfus — 21.64%
  3. Regeneron Pharmaceuticals Inc — 9.09%
  4. Amgen Inc — 7.95%
  5. Vertex Pharmaceuticals Inc — 7.84%
  6. Gilead Sciences Inc — 7.58%
  7. Argenx Se - Adr — 6.98%
  8. Goldman Sachs Liq Es Fd A — 6.23%
  9. N/a — 2.83%
  10. N/a — 0.62%

CURE top 10

  1. Dreyfus — 18.79%
  2. Eli Lilly & Company — 10.41%
  3. N/a — 8.28%
  4. Goldman Sachs Liq Es Fd A — 8.19%
  5. Goldman Financial — 7.51%
  6. Johnson & Johnson — 7.07%
  7. Abbvie Inc — 5.08%
  8. Unitedhealth Group Inc — 4.31%
  9. Merck & Company Inc — 3.68%
  10. N/a — 3.34%

FAQ

What is the difference between TBXU and CURE?
TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF) and CURE (Direxion Daily Healthcare Bull 3X ETF) are quite different portfolios: only about 39% of their top holdings (by weight) are shared. But CURE is far broader, holding 67 positions to 10 for TBXU, so beyond the top names it adds exposure TBXU doesn't have.
Which is cheaper, TBXU or CURE?
CURE has the lower expense ratio (0.94%).
Should I own both TBXU and CURE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.